Warning! GuruFocus detected
1 Severe warning sign
with NVNO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
enVVeno Medical Corp
NAICS : 339113
SIC : 3841
ISIN : US41015N1063
Share Class Description:
NVNO: Ordinary SharesDescription
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 40.56 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 10.5 | |||||
| 3-Year EPS without NRI Growth Rate | 11 | |||||
| 3-Year FCF Growth Rate | 11.2 | |||||
| 3-Year Book Growth Rate | -25.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 72.86 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.21 | |||||
| 9-Day RSI | 19.05 | |||||
| 14-Day RSI | 26.24 | |||||
| 3-1 Month Momentum % | -10.41 | |||||
| 6-1 Month Momentum % | -6.8 | |||||
| 12-1 Month Momentum % | -41.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 20.88 | |||||
| Quick Ratio | 20.88 | |||||
| Cash Ratio | 20.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.8 | |||||
| Shareholder Yield % | -32.05 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -50.39 | |||||
| ROA % | -47.47 | |||||
| ROIC % | -1013.44 | |||||
| 3-Year ROIIC % | 565.5 | |||||
| ROC (Joel Greenblatt) % | -1664.76 | |||||
| ROCE % | -53.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.95 | |||||
| Price-to-Tangible-Book | 0.95 | |||||
| EV-to-EBIT | -0.04 | |||||
| EV-to-EBITDA | -0.05 | |||||
| EV-to-FCF | -0.06 | |||||
| Price-to-Net-Current-Asset-Value | 0.98 | |||||
| Price-to-Net-Cash | 1 | |||||
| Earnings Yield (Greenblatt) % | -2500 | |||||
| FCF Yield % | -42.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NVNO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
enVVeno Medical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.27 | ||
| Beta | 1.26 | ||
| 3-Year Sharpe Ratio | 0.1 | ||
| 3-Year Sortino Ratio | 0.17 | ||
| Volatility % | 42.79 | ||
| 14-Day RSI | 26.24 | ||
| 14-Day ATR ($) | 0.241667 | ||
| 20-Day SMA ($) | 2.778 | ||
| 12-1 Month Momentum % | -41.55 | ||
| 52-Week Range ($) | 2.217 - 6.48 | ||
| Shares Outstanding (Mil) | 17.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
enVVeno Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
enVVeno Medical Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
enVVeno Medical Corp Frequently Asked Questions
What is enVVeno Medical Corp(NVNO)'s stock price today?
The current price of NVNO is $2.29. The 52 week high of NVNO is $6.48 and 52 week low is $2.22.
When is next earnings date of enVVeno Medical Corp(NVNO)?
The next earnings date of enVVeno Medical Corp(NVNO) is 2025-05-08 Est..
Does enVVeno Medical Corp(NVNO) pay dividends? If so, how much?
enVVeno Medical Corp(NVNO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers